The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...

FDA approves Symbravo for acute migraine relief, combining rizatriptan and meloxicam. Discover its unique benefits and fast ...

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective ...

A history of migraine, with or without aura, was a significant risk factor for open-angle glaucoma onset among a cohort of ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

The rocker returned to the stage in a wheelchair, and later told fans the incident "does not merit so much attention" ...

The global prevalence and incidence of migraine significantly increased from 1990 to 2021, with faster growth rates predicted in men and adolescents through 2050.

Thank you everyone for your concern,” Smith assured fans after having to leave the stage in São Paulo, Brazil. ”Trust me I am ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...